Abstract
The officially reported daily Covid-19 fatality rate is modelled with a trend line based on a nominal day-to-day reproduction rate and a cosine to take account of weekly fluctuations. Although the time trajectories of officially reported infections and fatalities are pronouncedly different, the reproduction rates obtained therefrom are similar. The long-term effective reproduction rate is around 0.835 and the administrative measures to contain the pandemic seem not to have an immediate reducing effect but well the ease of restrictions an increasing one. The fatality trajectory represented by its trend line can be projected from the number of daily infections by assuming a time lapse between symptom onset and death between 17 and 19 days and a time-dependent nominal lethality. The time trajectory of this lethality increases from 2.5% at March 16 when public life was restricted to 6% within 20 days indicating relatively more infections of vulnerable people. After stipulating face mask wearing at April 27, the nominal lethality decreases down to 1% later in summer. A detailed analysis shows that mask wearing really reduces the number of fatal infections and the officially reported daily infections in May and June are less lethal than before.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
I use only publicly available data from the Robert Koch Institute. Approval is not necessary.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
1
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos